Phio Pharmaceuticals Corp. (PHIO)
NASDAQ · Healthcare
Phio Pharmaceuticals Corp. Revenue 2012–2020
Phio Pharmaceuticals Corp. annual/quarterly revenue history and growth rate from 2012 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Phio Pharmaceuticals Corp. revenue for the quarter ending September 30, 2020 was 0.
- Phio Pharmaceuticals Corp. revenue for the twelve months ending September 30, 2020 was 0, a 100.00% decrease year-over-year.
- Phio Pharmaceuticals Corp. annual revenue for 2020 was 0, a 100.00% decrease from 2019.
- Phio Pharmaceuticals Corp. annual revenue for 2019 was 21000, a 84.78% decrease from 2018.
- Phio Pharmaceuticals Corp. annual revenue for 2018 was 138000, a 820.00% increase from 2017.
- Phio Pharmaceuticals Corp. annual revenue for 2017 was 15000.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Phio Pharmaceuticals Corp. (PHIO) — Frequently Asked Questions
Phio Pharmaceuticals Corp. (PHIO) is a publicly traded US company. It has a market capitalization of $6M. Explore PHIO's stock price, financial statements, earnings history, margins and key ratios below.
What is Phio Pharmaceuticals Corp.'s market cap?
Phio Pharmaceuticals Corp. (PHIO) has a market capitalization of $6M.
What is the PHIO stock price?
PHIO trades at $1.06 (-1.85% on the day).
Is PHIO profitable?
In fiscal 2020, Phio Pharmaceuticals Corp. reported net income of -$9M.